Immunohistochemical Markers for Prostatic Cancer
Authors:
- 1 December 1983
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 420 (1) , 134-139
Abstract
In a patient with an unclassifiable primary or metastatic neoplasm, with or without a history of prostatic cancer, immunostaining for PA or PSAP may prove invaluable. The procedure is simple, rapid, inexpensive, and extremely accurate in demonstrating the prostatic origin of tumors. It should be noted however, that the specificity of results is entirely dependent upon the specificity of the primary antibody, which should be meticulously defined before the procedure is used for diagnostic purposes.Keywords
This publication has 9 references indexed in Scilit:
- Prostatic-specific antigen: An immunohistologic marker for prostatic neoplasmsCancer, 1981
- Immunohistochemical Evaluation of Prostatic Carcinoma Before and After RadiotherapyJournal of Urology, 1980
- Immunohistochemical diagnosis of prostatic cancer with metastasisCancer, 1980
- ACID PHOSPHATASE AS MARKER FOR CARCINOMA OF PROSTATEThe Lancet, 1979
- IMMUNOHISTOLOGICAL DEMONSTRATION OF PROSTATIC ORIGIN OF MALIGNANT NEOPLASMSThe Lancet, 1979
- Indirect Immunofluorescence for Identification of Prostatic Epithelial CellsJournal of Urology, 1977
- Acid-phosphatase activity in human neoplasmsCancer, 1957
- Metastases, simulating mammary cancer, in prostatic carcinoma under estrogenic therapyCancer, 1951
- Anti-histamine effect of sodium salicylate and its bearing upon the skin-diffusing activity of hyaluronidaseBiochemical Journal, 1948